Request Deal Involvement

Celgene Corporation acquired Juno Therapeutics for $9bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Morgan Stanley

financial advisors

Morgan Stanley

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

Sullivan & Cromwell

legal advisors to financial advisors

Sullivan & Cromwell

Hogan Lovells

legal advisors

Hogan Lovells

Simpson Thacher & Bartlett

legal advisors

Simpson Thacher & Bartlett

JP Morgan

financial advisors

JP Morgan

Proskauer Rose

legal advisors

Proskauer Rose

or

Principals

JUNO THERAPEUTICS INC

target

JUNO THERAPEUTICS INC

CELGENE CORPORATION

bidder

CELGENE CORPORATION

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite